BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32708512)

  • 1. Radiomics for Tumor Characterization in Breast Cancer Patients: A Feasibility Study Comparing Contrast-Enhanced Mammography and Magnetic Resonance Imaging.
    Marino MA; Leithner D; Sung J; Avendano D; Morris EA; Pinker K; Jochelson MS
    Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32708512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrast-Enhanced Mammography and Radiomics Analysis for Noninvasive Breast Cancer Characterization: Initial Results.
    Marino MA; Pinker K; Leithner D; Sung J; Avendano D; Morris EA; Jochelson M
    Mol Imaging Biol; 2020 Jun; 22(3):780-787. PubMed ID: 31463822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
    Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
    J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiomics and artificial intelligence analysis by T2-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging to predict Breast Cancer Histological Outcome.
    Petrillo A; Fusco R; Barretta ML; Granata V; Mattace Raso M; Porto A; Sorgente E; Fanizzi A; Massafra R; Lafranceschina M; La Forgia D; Trombadori CML; Belli P; Trecate G; Tenconi C; De Santis MC; Greco L; Ferranti FR; De Soccio V; Vidiri A; Botta F; Dominelli V; Cassano E; Boldrini L
    Radiol Med; 2023 Nov; 128(11):1347-1371. PubMed ID: 37801198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer.
    Demircioglu A; Grueneisen J; Ingenwerth M; Hoffmann O; Pinker-Domenig K; Morris E; Haubold J; Forsting M; Nensa F; Umutlu L
    PLoS One; 2020; 15(6):e0234871. PubMed ID: 32589681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
    Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
    Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporating the clinical and radiomics features of contrast-enhanced mammography to classify breast lesions: a retrospective study.
    Wang S; Sun Y; Mao N; Duan S; Li Q; Li R; Jiang T; Wang Z; Xie H; Gu Y
    Quant Imaging Med Surg; 2021 Oct; 11(10):4418-4430. PubMed ID: 34603996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between 3T apparent diffusion coefficient values and grading of invasive breast carcinoma.
    Cipolla V; Santucci D; Guerrieri D; Drudi FM; Meggiorini ML; de Felice C
    Eur J Radiol; 2014 Dec; 83(12):2144-2150. PubMed ID: 25305145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for the Prediction of Sentinel Lymph Node Metastasis in Breast Cancer.
    Liu J; Sun D; Chen L; Fang Z; Song W; Guo D; Ni T; Liu C; Feng L; Xia Y; Zhang X; Li C
    Front Oncol; 2019; 9():980. PubMed ID: 31632912
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of Performance in Diagnosis and Characterization of Breast Lesions: Contrast-Enhanced Mammography Versus Breast Magnetic Resonance Imaging.
    Açar ÇR; Orguc S
    Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38777678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Prediction of Extramural Venous Invasion in Rectal Cancer: Comparison of the Diagnostic Efficacy of Radiomics Models and Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Yu X; Song W; Guo D; Liu H; Zhang H; He X; Song J; Zhou J; Liu X
    Front Oncol; 2020; 10():459. PubMed ID: 32328461
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics.
    Leithner D; Mayerhoefer ME; Martinez DF; Jochelson MS; Morris EA; Thakur SB; Pinker K
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32545851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer.
    Sumkin JH; Berg WA; Carter GJ; Bandos AI; Chough DM; Ganott MA; Hakim CM; Kelly AE; Zuley ML; Houshmand G; Anello MI; Gur D
    Radiology; 2019 Dec; 293(3):531-540. PubMed ID: 31660801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-Enhanced Mammography versus Breast Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis.
    Gelardi F; Ragaini EM; Sollini M; Bernardi D; Chiti A
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of MRI contrast enhancement in biopsy decision of suspicious mammographic microcalcifications: a prospective multicenter study.
    Taskin F; Kalayci CB; Tuncbilek N; Soydemir E; Kurt N; Kaya H; Aribal E
    Eur Radiol; 2021 Mar; 31(3):1718-1726. PubMed ID: 32939619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of Contrast-Enhanced Breast MRI vs X-ray Mammography Based on Cancer Histology, Tumor Grading, Receptor Status, and Molecular Subtype: A Supplemental Analysis of 2 Large Phase III Studies.
    Endrikat J; Schmidt G; Haverstock D; Weber O; Trnkova ZJ; Barkhausen J
    Breast Cancer (Auckl); 2022; 16():11782234221092155. PubMed ID: 35462754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer.
    Liu M; Mao N; Ma H; Dong J; Zhang K; Che K; Duan S; Zhang X; Shi Y; Xie H
    Cancer Imaging; 2020 Sep; 20(1):65. PubMed ID: 32933585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent diffusion coefficient on 3.0 Tesla magnetic resonance imaging and prognostic factors in breast cancer.
    De Felice C; Cipolla V; Guerrieri D; Santucci D; Musella A; Porfiri LM; Meggiorini ML
    Eur J Gynaecol Oncol; 2014; 35(4):408-14. PubMed ID: 25118482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
    Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
    J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.